financetom
Business
financetom
/
Business
/
Numinus Wellness Fiscal Q3 Loss Down Vs Fiscal Q2 Loss, Even As Revenue Fell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Numinus Wellness Fiscal Q3 Loss Down Vs Fiscal Q2 Loss, Even As Revenue Fell
Jul 11, 2024 2:33 PM

05:01 PM EDT, 07/11/2024 (MT Newswires) -- Numinus Wellness ( NUMIF ). (NUMI.TO), a mental health care company, after trade Thursday said it reduced losses in its fiscal third quarter, compared to the prior quarter, even as revenues were down.

NUMI reported loss and comprehensive loss for the third quarter ended May 31, of $5.13 million compared to a loss and comprehensive loss for the fiscal second quarter ended February 29 of $5,71 million.

It reported revenue of $4.3 million, a 1.9% decline from fiscal Q2.

Among other highlights, NUMI said it had a cash position of $3.7 million as of May 31.. It noted that on June 20 it executed a letter of intent to acquire MedBright AI Investments Inc. ( MBAIF ) by way of a statutory plan of arrangement. Under the terms of the LOI, the company will issue 1.86 shares of Numinus for each MedBright share, making up an aggregate of approximately 204,729,372 of the company's shares.

Numinus shares closed up $0.005 to $0.045 on the Toronto Stock Exchange, leaving it at the low end of its 52-week trading range.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ReAlpha Tech Shares Jump After Q2 Revenue Rises
ReAlpha Tech Shares Jump After Q2 Revenue Rises
Aug 15, 2024
03:18 PM EDT, 08/15/2024 (MT Newswires) -- ReAlpha Tech ( AIRE ) shares rose more than 10% in recent trading Thursday after the real estate technology company posted higher revenue in Q2. The company reported its Q2 swung to a loss of $0.03 per diluted share from earnings of $0.11 a year earlier. Analysts' estimates weren't available. Revenue for the...
Abercrombie & Fitch Q2 Momentum Seen Supporting Q2 EPS Beat, Guidance Boost, UBS Says
Abercrombie & Fitch Q2 Momentum Seen Supporting Q2 EPS Beat, Guidance Boost, UBS Says
Aug 15, 2024
03:15 PM EDT, 08/15/2024 (MT Newswires) -- Abercrombie & Fitch's ( ANF ) Q2 sales momentum may lead earnings per share to top estimates by 16 cents and spur a boost in 2024 guidance, UBS Securities said Thursday in a report. Wall Street is already modeling 2024 EPS above the company's implied outlook, likely limiting the extent of upward revisions...
US Government Sets Out Prices of 10 Drugs in Medicare Negotiations
US Government Sets Out Prices of 10 Drugs in Medicare Negotiations
Aug 15, 2024
03:16 PM EDT, 08/15/2024 (MT Newswires) -- The Biden administration on Thursday set out prices for 10 prescription drugs, including those from Johnson & Johnson ( JNJ ) and Merck ( MRK ) , that were selected for negotiations between the Medicare program and drugmakers under the 2022 Inflation Reduction Act. The new prices will be effective for people with...
Looking At GE Aero's Recent Unusual Options Activity
Looking At GE Aero's Recent Unusual Options Activity
Aug 15, 2024
Investors with a lot of money to spend have taken a bullish stance on GE Aero . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved